ADDA5 hydrochloride is used as a partial non-competitive inhibitor of cytochrome c oxidase (CcO) for studying its role in cellular respiration and cancer metabolism; it exhibits growth-inhibitory effects on human glioma cells (e.g., UTMZ cells, EC50 = 8.17 μM) and glioma stem-like cells (GSCs); it significantly suppresses tumor growth in mouse xenograft models when administered intraperitoneally at 8 mg/kg; and it shows potential as an anticancer agent with low detectable toxicity in vivo (up to 80 mg/kg in mice).